Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambrisentan for Digital Ulcers in Systemic Sclerosis
NCT00725361Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jun 2008
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ambrisentan in Digital ulcer, sponsored by Stanford University. Started Jun 2008; status: completed.
02
Drugs
ambrisentan
03
Conditions
Digital ulcer
Beyond the preview
Go deeper on NCT00725361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00725361.